Artwork
iconShare
 
Manage episode 522348987 series 1153244
Content provided by Horse Radio Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Horse Radio Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Short Summary: Dr. Holly Helbig and Dr. David Levine describe how they use SAA and other biomarkers to spot infection early, guide treatment, support biosecurity, and monitor horses in real time.

Landing page copy: Acute phase proteins such as serum amyloid A (SAA) give veterinarians an early look at inflammation, infection, and how a horse responds to treatment. In this Equine Innovators episode, we dig into how SAA and other key biomarkers guide everyday decisions—from biosecurity on busy farms and showgrounds to managing postoperative cases, colic, and foal exams.

Host Stephanie Church, editorial director at The Horse, talks with Dr. Holly Helbig of Zoetis and Dr. David Levine from the University of Pennsylvania’s New Bolton Center about when they reach for SAA, how it compares with fibrinogen and white blood cell counts, and why serial testing often matters more than any single number. They share stall-side and hospital protocols, real-world case examples, and ways biomarker trends support smarter antimicrobial use and quarantine decisions.

In this episode, Drs. Helbig and Levine discuss:

  • What acute phase proteins are and how SAA reflects early inflammation in horses
  • How fast SAA and fibrinogen rise and fall, and how that timing shapes testing plans
  • When stallside SAA testing shines in ambulatory practice, at horse shows, and on the farm
  • Using SAA to help sort out joint flares vs. septic joints and guide post-surgical monitoring
  • Practical cutoffs and patterns for foals, including how vaccination and IV plasma affect SAA
  • Where SAA fits into antimicrobial stewardship and cost-conscious biosecurity strategies
  • Emerging research and what might come next for biomarkers in equine practice

Tune in to hear how two equine veterinarians lean on SAA and other biomarkers to clarify tough calls, support horse owners, and keep diagnostics and treatments on the right track.

GUESTS AND LINKS – EPISODE 23:


  continue reading

3044 episodes